Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review
Abstract
:1. Introduction
2. Materials and Methods
2.1. Type of Study and Objectives
2.2. Eligibility Criteria
3. Results
3.1. Screening of Original Articles
3.2. Selected Original Articles
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Chesney, J.A.; Mitchell, R.A.; Yaddanapudi, K. Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy. J. Leukoc. Biol. 2017, 102, 727–740. [Google Scholar] [CrossRef]
- Veglia, F.; Sanseviero, E.; Gabrilovich, D.I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat. Rev. Immunol. 2021, 21, 485–498. [Google Scholar] [CrossRef]
- Talmadge, J.E.; Gabrilovich, D.I. History of myeloid-derived suppressor cells. Nat. Rev. Cancer 2013, 13, 739–752. [Google Scholar] [CrossRef] [PubMed]
- Hofer, F.; Di Sario, G.; Musiu, C.; Sartoris, S.; De Sanctis, F.; Ugel, S. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment. Cells 2021, 10, 2700. [Google Scholar] [CrossRef]
- Trovato, R.; Cane, S.; Petrova, V.; Sartoris, S.; Ugel, S.; De Sanctis, F. The Engagement Between MDSCs and Metastases: Partners in Crime. Front. Oncol. 2020, 10, 165. [Google Scholar] [CrossRef]
- Sanchez-Pino, M.D.; Dean, M.J.; Ochoa, A.C. Myeloid-derived suppressor cells (MDSC): When good intentions go awry. Cell Immunol. 2021, 362, 104302. [Google Scholar] [CrossRef] [PubMed]
- Ostrand-Rosenberg, S.; Fenselau, C. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment. J. Immunol. 2018, 200, 422–431. [Google Scholar] [CrossRef] [PubMed]
- Davidsson, S.; Fiorentino, M.; Giunchi, F.; Eriksson, M.; Erlandsson, A.; Sundqvist, P.; Carlsson, J. Infiltration of M2 Macrophages and Regulatory T Cells Plays a Role in Recurrence of Renal Cell Carcinoma. Eur. Urol. Open Sci. 2020, 20, 62–71. [Google Scholar] [CrossRef]
- Haist, M.; Stege, H.; Grabbe, S.; Bros, M. The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment. Cancers 2021, 13, 210. [Google Scholar] [CrossRef]
- Draghiciu, O.; Lubbers, J.; Nijman, H.W.; Daemen, T. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy. Oncoimmunology 2015, 4, e954829. [Google Scholar] [CrossRef]
- Ramos-Lopez, O.; Martinez-Urbistondo, D.; Vargas-Nunez, J.A.; Martinez, J.A. The Role of Nutrition on Meta-inflammation: Insights and Potential Targets in Communicable and Chronic Disease Management. Curr. Obes. Rep. 2022, 11, 305–335. [Google Scholar] [CrossRef]
- Mentella, M.C.; Scaldaferri, F.; Ricci, C.; Gasbarrini, A.; Miggiano, G.A.D. Cancer and Mediterranean Diet: A Review. Nutrients 2019, 11, 2059. [Google Scholar] [CrossRef] [PubMed]
- Talib, W.H.; Mahmod, A.I.; Kamal, A.; Rashid, H.M.; Alashqar, A.M.D.; Khater, S.; Jamal, D.; Waly, M. Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities. Curr. Issues Mol. Biol. 2021, 43, 558–589. [Google Scholar] [CrossRef]
- Turati, F.; Galeone, C.; Augustin, L.S.A.; La Vecchia, C. Glycemic Index, Glycemic Load and Cancer Risk: An Updated Meta-Analysis. Nutrients 2019, 11, 2342. [Google Scholar] [CrossRef]
- Hu, J.; Wang, J.; Li, Y.; Xue, K.; Kan, J. Use of Dietary Fibers in Reducing the Risk of Several Cancer Types: An Umbrella Review. Nutrients 2023, 15, 2545. [Google Scholar] [CrossRef]
- Hardt, L.; Mahamat-Saleh, Y.; Aune, D.; Schlesinger, S. Plant-Based Diets and Cancer Prognosis: A Review of Recent Research. Curr. Nutr. Rep. 2022, 11, 695–716. [Google Scholar] [CrossRef]
- Ashari, L.S.; Abd Rashid, A.A.; Mohd Razif, S.; Yeong Yeh, L.; Jan Mohamed, H.J. Diet is Linked to Colorectal Cancer Risk among Asian Adults: A Scoping Review. Malays. J. Med. Sci. 2023, 30, 8–31. [Google Scholar] [CrossRef] [PubMed]
- Han, E.; Lee, E.; Sukhu, B.; Garcia, J.; Lopez Castillo, H. The relationship between dietary inflammatory potential and cancer outcomes among cancer survivors: A systematic review and meta-analysis of cohort studies. Transl. Oncol. 2023, 38, 101798. [Google Scholar] [CrossRef] [PubMed]
- Clifton, K.K.; Ma, C.X.; Fontana, L.; Peterson, L.L. Intermittent fasting in the prevention and treatment of cancer. CA Cancer J. Clin. 2021, 71, 527–546. [Google Scholar] [CrossRef] [PubMed]
- Ubago-Guisado, E.; Rodriguez-Barranco, M.; Ching-Lopez, A.; Petrova, D.; Molina-Montes, E.; Amiano, P.; Barricarte-Gurrea, A.; Chirlaque, M.D.; Agudo, A.; Sanchez, M.J. Evidence Update on the Relationship between Diet and the Most Common Cancers from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: A Systematic Review. Nutrients 2021, 13, 3582. [Google Scholar] [CrossRef]
- Porta, C.; Marino, A.; Consonni, F.M.; Bleve, A.; Mola, S.; Storto, M.; Riboldi, E.; Sica, A. Metabolic influence on the differentiation of suppressive myeloid cells in cancer. Carcinogenesis 2018, 39, 1095–1104. [Google Scholar] [CrossRef] [PubMed]
- Fleet, J.C.; Burcham, G.N.; Calvert, R.D.; Elzey, B.D.; Ratliff, T.L. 1alpha, 25 Dihydroxyvitamin D (1,25(OH)(2)D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC). J. Steroid Biochem. Mol. Biol. 2020, 198, 105557. [Google Scholar] [CrossRef]
- Sun, H.W.; Chen, J.; Wu, W.C.; Yang, Y.Y.; Xu, Y.T.; Yu, X.J.; Chen, H.T.; Wang, Z.; Wu, X.J.; Zheng, L. Retinoic Acid Synthesis Deficiency Fosters the Generation of Polymorphonuclear Myeloid-Derived Suppressor Cells in Colorectal Cancer. Cancer Immunol. Res. 2021, 9, 20–33. [Google Scholar] [CrossRef]
- Lorin, J.; Zeller, M.; Guilland, J.C.; Cottin, Y.; Vergely, C.; Rochette, L. Arginine and nitric oxide synthase: Regulatory mechanisms and cardiovascular aspects. Mol. Nutr. Food Res. 2014, 58, 101–116. [Google Scholar] [CrossRef]
- Albeituni, S.H.; Ding, C.; Yan, J. Hampering immune suppressors: Therapeutic targeting of myeloid-derived suppressor cells in cancer. Cancer J. 2013, 19, 490–501. [Google Scholar] [CrossRef] [PubMed]
- Ma, W.; Heianza, Y.; Huang, T.; Wang, T.; Sun, D.; Zheng, Y.; Hu, F.B.; Rexrode, K.M.; Manson, J.E.; Qi, L. Dietary glutamine, glutamate and mortality: Two large prospective studies in US men and women. Int. J. Epidemiol. 2018, 47, 311–320. [Google Scholar] [CrossRef] [PubMed]
- Oh, M.H.; Sun, I.H.; Zhao, L.; Leone, R.D.; Sun, I.M.; Xu, W.; Collins, S.L.; Tam, A.J.; Blosser, R.L.; Patel, C.H.; et al. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J. Clin. Investig. 2020, 130, 3865–3884. [Google Scholar] [CrossRef]
- Huang, Y.; Chen, Z.; Chen, B.; Li, J.; Yuan, X.; Li, J.; Wang, W.; Dai, T.; Chen, H.; Wang, Y.; et al. Dietary sugar consumption and health: Umbrella review. BMJ 2023, 381, e071609. [Google Scholar] [CrossRef]
- Kim, J.; Lee, H.; Choi, H.K.; Min, H. Discovery of Myeloid-Derived Suppressor Cell-Specific Metabolism by Metabolomic and Lipidomic Profiling. Metabolites 2023, 13, 477. [Google Scholar] [CrossRef]
- Golonko, A.; Pienkowski, T.; Swislocka, R.; Orzechowska, S.; Marszalek, K.; Szczerbinski, L.; Swiergiel, A.H.; Lewandowski, W. Dietary factors and their influence on immunotherapy strategies in oncology: A comprehensive review. Cell Death Dis. 2024, 15, 254. [Google Scholar] [CrossRef]
- Chen, H.M.; Sun, L.; Pan, P.Y.; Wang, L.H.; Chen, S.H. Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism. Cancer Immunol. Immunother. 2021, 70, 3435–3449. [Google Scholar] [CrossRef] [PubMed]
- Tao, H.; Liu, M.; Wang, Y.; Luo, S.; Xu, Y.; Ye, B.; Zheng, L.; Meng, K.; Li, L. Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation. Front. Immunol. 2021, 12, 609295. [Google Scholar] [CrossRef]
- Long, A.H.; Highfill, S.L.; Cui, Y.; Smith, J.P.; Walker, A.J.; Ramakrishna, S.; El-Etriby, R.; Galli, S.; Tsokos, M.G.; Orentas, R.J.; et al. Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas. Cancer Immunol. Res. 2016, 4, 869–880. [Google Scholar] [CrossRef]
- Rui, K.; Tian, J.; Tang, X.; Ma, J.; Xu, P.; Tian, X.; Wang, Y.; Xu, H.; Lu, L.; Wang, S. Curdlan blocks the immune suppression by myeloid-derived suppressor cells and reduces tumor burden. Immunol. Res. 2016, 64, 931–939. [Google Scholar] [CrossRef] [PubMed]
- Lesinski, G.B.; Reville, P.K.; Mace, T.A.; Young, G.S.; Ahn-Jarvis, J.; Thomas-Ahner, J.; Vodovotz, Y.; Ameen, Z.; Grainger, E.; Riedl, K.; et al. Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells. Cancer Prev. Res. 2015, 8, 1036–1044. [Google Scholar] [CrossRef]
- Xu, P.; Yan, F.; Zhao, Y.; Chen, X.; Sun, S.; Wang, Y.; Ying, L. Green Tea Polyphenol EGCG Attenuates MDSCs-mediated Immunosuppression through Canonical and Non-Canonical Pathways in a 4T1 Murine Breast Cancer Model. Nutrients 2020, 12, 1042. [Google Scholar] [CrossRef]
- Bondhopadhyay, B.; Sisodiya, S.; Chikara, A.; Khan, A.; Tanwar, P.; Afroze, D.; Singh, N.; Agrawal, U.; Mehrotra, R.; Hussain, S. Cancer immunotherapy: A promising dawn in cancer research. Am. J. Blood Res. 2020, 10, 375–385. [Google Scholar]
- Nguyen, K.A.; DePledge, L.N.; Bian, L.; Ke, Y.; Samedi, V.; Berning, A.A.; Owens, P.; Wang, X.J.; Young, C.D. Polymorphonuclear myeloid-derived suppressor cells and phosphatidylinositol-3 kinase gamma are critical to tobacco-mimicking oral carcinogenesis in mice. J. Immunother. Cancer 2023, 11, e007110. [Google Scholar] [CrossRef]
- Ostrand-Rosenberg, S. Myeloid derived-suppressor cells: Their role in cancer and obesity. Curr. Opin. Immunol. 2018, 51, 68–75. [Google Scholar] [CrossRef]
- Jimenez-Cortegana, C.; Lopez-Saavedra, A.; Sanchez-Jimenez, F.; Perez-Perez, A.; Castineiras, J.; Virizuela-Echaburu, J.A.; de la Cruz-Merino, L.; Sanchez-Margalet, V. Leptin, Both Bad and Good Actor in Cancer. Biomolecules 2021, 11, 913. [Google Scholar] [CrossRef]
- Kim, S.H.; Roszik, J.; Grimm, E.A.; Ekmekcioglu, S. Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy. Front. Oncol. 2018, 8, 67. [Google Scholar] [CrossRef]
- Wetzel, T.J.; Erfan, S.C.; Figueroa, L.D.; Wheeler, L.M.; Ananieva, E.A. Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment. Front. Oncol. 2023, 13, 1186539. [Google Scholar] [CrossRef]
- Raber, P.; Ochoa, A.C.; Rodriguez, P.C. Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: Mechanisms of T cell suppression and therapeutic perspectives. Immunol. Investig. 2012, 41, 614–634. [Google Scholar] [CrossRef] [PubMed]
- Ozbay Kurt, F.G.; Lasser, S.; Arkhypov, I.; Utikal, J.; Umansky, V. Enhancing immunotherapy response in melanoma: Myeloid-derived suppressor cells as a therapeutic target. J. Clin. Investig. 2023, 133, e170762. [Google Scholar] [CrossRef]
- Yan, D.; Adeshakin, A.O.; Xu, M.; Afolabi, L.O.; Zhang, G.; Chen, Y.H.; Wan, X. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor. Front. Immunol. 2019, 10, 1399. [Google Scholar] [CrossRef]
- Veglia, F.; Tyurin, V.A.; Blasi, M.; De Leo, A.; Kossenkov, A.V.; Donthireddy, L.; To, T.K.J.; Schug, Z.; Basu, S.; Wang, F.; et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature 2019, 569, 73–78. [Google Scholar] [CrossRef]
- Chen, Y.; Xu, Y.; Zhao, H.; Zhou, Y.; Zhang, J.; Lei, J.; Wu, L.; Zhou, M.; Wang, J.; Yang, S.; et al. Myeloid-derived suppressor cells deficient in cholesterol biosynthesis promote tumor immune evasion. Cancer Lett. 2023, 564, 216208. [Google Scholar] [CrossRef]
- Talib, W.H.; Ahmed Jum, A.D.; Attallah, Z.S.; Jallad, M.S.; Al Kury, L.T.; Hadi, R.W.; Mahmod, A.I. Role of vitamins A, C, D, E in cancer prevention and therapy: Therapeutic potentials and mechanisms of action. Front. Nutr. 2023, 10, 1281879. [Google Scholar] [CrossRef]
- Lim, H.X.; Kim, T.S.; Poh, C.L. Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers. Int. J. Mol. Sci. 2020, 21, 3599. [Google Scholar] [CrossRef] [PubMed]
- Nefedova, Y.; Fishman, M.; Sherman, S.; Wang, X.; Beg, A.A.; Gabrilovich, D.I. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Res. 2007, 67, 11021–11028. [Google Scholar] [CrossRef]
- Lee, G.Y.; Han, S.N. The Role of Vitamin E in Immunity. Nutrients 2018, 10, 1614. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; He, Q.; Rong, K.; Zhu, M.; Zhao, X.; Zheng, P.; Mi, Y. Vitamin D3 promotes gastric cancer cell autophagy by mediating p53/AMPK/mTOR signaling. Front. Pharmacol. 2023, 14, 1338260. [Google Scholar] [CrossRef]
- Fleet, J.C.; DeSmet, M.; Johnson, R.; Li, Y. Vitamin D and cancer: A review of molecular mechanisms. Biochem. J. 2012, 441, 61–76. [Google Scholar] [CrossRef]
- Jeon, S.M.; Shin, E.A. Exploring vitamin D metabolism and function in cancer. Exp. Mol. Med. 2018, 50, 1–14. [Google Scholar] [CrossRef]
- Samuel, S.; Sitrin, M.D. Vitamin D’s role in cell proliferation and differentiation. Nutr. Rev. 2008, 66, S116–S124. [Google Scholar] [CrossRef]
- Jimenez-Cortegana, C.; Sanchez-Martinez, P.M.; Palazon-Carrion, N.; Nogales-Fernandez, E.; Henao-Carrasco, F.; Martin Garcia-Sancho, A.; Rueda, A.; Provencio, M.; de la Cruz-Merino, L.; Sanchez-Margalet, V. Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial. Cancers 2021, 13, 4622. [Google Scholar] [CrossRef] [PubMed]
- Kim, H.S.; Quon, M.J.; Kim, J.A. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol. 2014, 2, 187–195. [Google Scholar] [CrossRef]
- Almatroodi, S.A.; Almatroudi, A.; Khan, A.A.; Alhumaydhi, F.A.; Alsahli, M.A.; Rahmani, A.H. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. Molecules 2020, 25, 3146. [Google Scholar] [CrossRef]
- Gan, R.Y.; Li, H.B.; Sui, Z.Q.; Corke, H. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Crit. Rev. Food Sci. Nutr. 2018, 58, 924–941. [Google Scholar] [CrossRef]
- Hayakawa, S.; Ohishi, T.; Miyoshi, N.; Oishi, Y.; Nakamura, Y.; Isemura, M. Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid. Molecules 2020, 25, 4553. [Google Scholar] [CrossRef]
- Negri, A.; Naponelli, V.; Rizzi, F.; Bettuzzi, S. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer. Nutrients 2018, 10, 1936. [Google Scholar] [CrossRef] [PubMed]
- Mokra, D.; Adamcakova, J.; Mokry, J. Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases? Antioxidants 2022, 11, 1566. [Google Scholar] [CrossRef] [PubMed]
- Varinska, L.; Gal, P.; Mojzisova, G.; Mirossay, L.; Mojzis, J. Soy and breast cancer: Focus on angiogenesis. Int. J. Mol. Sci. 2015, 16, 11728–11749. [Google Scholar] [CrossRef]
- Applegate, C.C.; Rowles, J.L.; Ranard, K.M.; Jeon, S.; Erdman, J.W. Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis. Nutrients 2018, 10, 40. [Google Scholar] [CrossRef]
- Boutas, I.; Kontogeorgi, A.; Dimitrakakis, C.; Kalantaridou, S.N. Soy Isoflavones and Breast Cancer Risk: A Meta-analysis. In Vivo 2022, 36, 556–562. [Google Scholar] [CrossRef] [PubMed]
- Chaudhari, V.; Buttar, H.S.; Bagwe-Parab, S.; Tuli, H.S.; Vora, A.; Kaur, G. Therapeutic and Industrial Applications of Curdlan With Overview on Its Recent Patents. Front. Nutr. 2021, 8, 646988. [Google Scholar] [CrossRef]
- Kim, H.S.; Park, K.H.; Lee, H.K.; Kim, J.S.; Kim, Y.G.; Lee, J.H.; Kim, K.H.; Yun, J.; Hwang, B.Y.; Hong, J.T.; et al. Curdlan activates dendritic cells through dectin-1 and toll-like receptor 4 signaling. Int. Immunopharmacol. 2016, 39, 71–78. [Google Scholar] [CrossRef]
- Tian, J.; Ma, J.; Ma, K.; Guo, H.; Baidoo, S.E.; Zhang, Y.; Yan, J.; Lu, L.; Xu, H.; Wang, S. beta-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells. Eur. J. Immunol. 2013, 43, 1220–1230. [Google Scholar] [CrossRef]
- Bersanelli, M.; Cortellini, A.; Leonetti, A.; Parisi, A.; Tiseo, M.; Bordi, P.; Michiara, M.; Bui, S.; Cosenza, A.; Ferri, L.; et al. Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: Results from the prospective PROVIDENCE study. Cancer Immunol. Immunother. 2023, 72, 3707–3716. [Google Scholar] [CrossRef]
- Magri, A.; Germano, G.; Lorenzato, A.; Lamba, S.; Chila, R.; Montone, M.; Amodio, V.; Ceruti, T.; Sassi, F.; Arena, S.; et al. High-dose vitamin C enhances cancer immunotherapy. Sci. Transl. Med. 2020, 12, eaay8707. [Google Scholar] [CrossRef]
- Westheim, A.J.F.; Stoffels, L.M.; Dubois, L.J.; van Bergenhenegouwen, J.; van Helvoort, A.; Langen, R.C.J.; Shiri-Sverdlov, R.; Theys, J. Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy. Front. Nutr. 2022, 9, 868436. [Google Scholar] [CrossRef]
- Guo, C.; You, Z.; Shi, H.; Sun, Y.; Du, X.; Palacios, G.; Guy, C.; Yuan, S.; Chapman, N.M.; Lim, S.A.; et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature 2023, 620, 200–208. [Google Scholar] [CrossRef] [PubMed]
- Zhang, J.; Wang, S.; Guo, X.; Lu, Y.; Liu, X.; Jiang, M.; Li, X.; Qin, B.; Luo, Z.; Liu, H.; et al. Arginine Supplementation Targeting Tumor-Killing Immune Cells Reconstructs the Tumor Microenvironment and Enhances the Antitumor Immune Response. ACS Nano 2022, 16, 12964–12978. [Google Scholar] [CrossRef]
- Liu, L.; Lim, M.A.; Jung, S.N.; Oh, C.; Won, H.R.; Jin, Y.L.; Piao, Y.; Kim, H.J.; Chang, J.W.; Koo, B.S. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer. Phytomedicine 2021, 92, 153758. [Google Scholar] [CrossRef] [PubMed]
- Liu, K.; Sun, Q.; Liu, Q.; Li, H.; Zhang, W.; Sun, C. Focus on immune checkpoint PD-1/PD-L1 pathway: New advances of polyphenol phytochemicals in tumor immunotherapy. Biomed. Pharmacother. 2022, 154, 113618. [Google Scholar] [CrossRef]
- Spencer, C.N.; McQuade, J.L.; Gopalakrishnan, V.; McCulloch, J.A.; Vetizou, M.; Cogdill, A.P.; Khan, M.A.W.; Zhang, X.; White, M.G.; Peterson, C.B.; et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science 2021, 374, 1632–1640. [Google Scholar] [CrossRef]
- Donnelly, J.; Appathurai, A.; Yeoh, H.L.; Driscoll, K.; Faisal, W. Vitamin E in Cancer Treatment: A Review of Clinical Applications in Randomized Control Trials. Nutrients 2022, 14, 4329. [Google Scholar] [CrossRef]
- Guo, Q.; Li, L.; Hou, S.; Yuan, Z.; Li, C.; Zhang, W.; Zheng, L.; Li, X. The Role of Iron in Cancer Progression. Front. Oncol. 2021, 11, 778492. [Google Scholar] [CrossRef]
- Rataan, A.O.; Geary, S.M.; Zakharia, Y.; Rustum, Y.M.; Salem, A.K. Potential Role of Selenium in the Treatment of Cancer and Viral Infections. Int. J. Mol. Sci. 2022, 23, 2215. [Google Scholar] [CrossRef]
Article | Study | Objective | Method | Results |
---|---|---|---|---|
Hui-Ming Chen et al. (2021) [31] | Pre-clinical | Role of selected vegetables on antitumor activity in lung cancer (LC). | LC mouse models with and without liver metastases treated with a mix of selected vegetables. | Significant tumor size reduction and survival improvement in mice fed with selected vegetables compared to control mice. Reduction in G-MDSC percentage and M-MDSC immunosuppressive function. |
Tao H et al. (2021) [32] | Pre-clinical | Effects of icaritin on the tumor microenvironment. | Mouse models with orthotopic and subcutaneous liver cancer treated with icaritin and anti-PD-1. | Significant tumor size reduction and survival improvement in mice treated with icaritin compared to control mice. Reduction in G-MDSC levels and activity. |
Long A et al. (2016) [33] | Pre-clinical | Effects of GD2-CAR-T therapy and all-trans retinoic acid (ATRA) on solid pediatric tumors. | Mouse models with osteosarcoma, Ewing’s sarcoma, rhabdomyosarcoma, and neuroblastoma treated with GD2-CAR-T and ATRA. The control group received only GD2-CAR-T. | ATRA combined with GD2-CAR-T delayed tumor growth and increased survival. MDSC were also decreased. |
Rui K et al. (2016) [34] | Pre-clinical | Effects of curdlan on MDSCs. | Mouse models with Lewis LC treated with curdlan for one week before the subcutaneous injection. | Significant reduction in tumor growth, splenic MDSC, arginase, and nitric oxide. |
Lesinski G et al. (2015) [35] | Phase II trial. | Efficacy and pharmacokinetics of soy phytochemicals. | Patients with biochemical relapse of prostate cancer, ECOG 0–1. Diet: (1) two soy-enriched bread slices per day for 8 weeks, (2) Legume-free diet for 2 weeks, and (3) two soy- and almond-enriched bread per day for 8 weeks. | Reduction in Th1, regulatory T cells (Treg), Treg/CD8 ratio, M-MDSCs and MDSC-related cytokines. Increase in natural killer cells. |
Fleet J et al. (2020) [22] | Pre-clinical | Role of the active form of vitamin D [1,25 (OH)2D] as a regulator of the activity of MDSCs. | Vitamin D receptor (VDR) KO Mouse models treated with 1,25 (OH)2D. | Vitamin D increased VDR levels and reduced MDSC capacity. Arginase levels were higher in VDR KO mice. |
Xu P et al. (2020) [36] | Pre-clinical | Action of EGCG on the activity of MDSCs in breast cancer. | 4T1 breast cancer-bearing mice treated with increasing doses of EGCG. | Tumor size was smaller in samples treated with EGCG. This compound improved the expression of cell death-related routes in MDSC and reduced the immunosuppressive capacity of MDSCs. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pérez-Peláez, B.; Jiménez-Cortegana, C.; de la Cruz-Merino, L.; Sánchez-Margalet, V. Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review. Curr. Issues Mol. Biol. 2024, 46, 9286-9297. https://doi.org/10.3390/cimb46090549
Pérez-Peláez B, Jiménez-Cortegana C, de la Cruz-Merino L, Sánchez-Margalet V. Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review. Current Issues in Molecular Biology. 2024; 46(9):9286-9297. https://doi.org/10.3390/cimb46090549
Chicago/Turabian StylePérez-Peláez, Beatriz, Carlos Jiménez-Cortegana, Luis de la Cruz-Merino, and Víctor Sánchez-Margalet. 2024. "Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review" Current Issues in Molecular Biology 46, no. 9: 9286-9297. https://doi.org/10.3390/cimb46090549